Cerity Partners LLC Biovie Inc. Transaction History

Cerity Partners LLC

  • $44.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$0.53 - $1.89 $22,260 - $79,380
42,000 Added 103.09%
82,741 $43,000
Q4 2023

Jan 26, 2024
BUY
$1.22 - $5.24 $6,222 - $26,724
5,100 Added 14.31%
40,741 $51,000
Q3 2023

Nov 13, 2023
BUY
$2.75 - $5.17 $98,012 - $184,263
35,641 New
35,641 $121,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $64.3M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email